Cargando…

RUNX Proteins as Epigenetic Modulators in Cancer

RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Hongyang, He, Yuhao, Zhu, Qionghua, Fang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688118/
https://www.ncbi.nlm.nih.gov/pubmed/36429115
http://dx.doi.org/10.3390/cells11223687
_version_ 1784836186211090432
author Yi, Hongyang
He, Yuhao
Zhu, Qionghua
Fang, Liang
author_facet Yi, Hongyang
He, Yuhao
Zhu, Qionghua
Fang, Liang
author_sort Yi, Hongyang
collection PubMed
description RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-β, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer.
format Online
Article
Text
id pubmed-9688118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96881182022-11-25 RUNX Proteins as Epigenetic Modulators in Cancer Yi, Hongyang He, Yuhao Zhu, Qionghua Fang, Liang Cells Review RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-β, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer. MDPI 2022-11-20 /pmc/articles/PMC9688118/ /pubmed/36429115 http://dx.doi.org/10.3390/cells11223687 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yi, Hongyang
He, Yuhao
Zhu, Qionghua
Fang, Liang
RUNX Proteins as Epigenetic Modulators in Cancer
title RUNX Proteins as Epigenetic Modulators in Cancer
title_full RUNX Proteins as Epigenetic Modulators in Cancer
title_fullStr RUNX Proteins as Epigenetic Modulators in Cancer
title_full_unstemmed RUNX Proteins as Epigenetic Modulators in Cancer
title_short RUNX Proteins as Epigenetic Modulators in Cancer
title_sort runx proteins as epigenetic modulators in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688118/
https://www.ncbi.nlm.nih.gov/pubmed/36429115
http://dx.doi.org/10.3390/cells11223687
work_keys_str_mv AT yihongyang runxproteinsasepigeneticmodulatorsincancer
AT heyuhao runxproteinsasepigeneticmodulatorsincancer
AT zhuqionghua runxproteinsasepigeneticmodulatorsincancer
AT fangliang runxproteinsasepigeneticmodulatorsincancer